棒傑股份(002634.SZ):簽訂9.12億元高效光伏電池片相關生產設備採購合同
格隆匯2月20日丨棒傑股份(002634.SZ)公佈,公司二級子公司揚州棒傑新能源科技有限公司(以下簡稱“揚州棒傑”)與深圳市捷佳偉創新能源裝備股份有限公司(以下簡稱“捷佳偉創”)及其全資子公司常州捷佳創精密機械有限公司(以下簡稱“常州捷佳創”)簽訂了《採購合同》,揚州棒傑擬向捷佳偉創及其全資子公司常州捷佳創採購高效光伏電池片相關生產設備,全部用於公司揚州市10GW高效光伏電池片項目。
本次的採購合同價格總額9.12億元,本次簽訂的《採購合同》有利於推進公司揚州市10GW高效光伏電池片項目的投產達效,本合同的順利履行預計對公司未來經營成果產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.